Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

SYSMEX-EUROPA

Sysmex Europe designs and produces laboratory and hematology diagnostic solutions, including instruments, reagents, c... read more Featured Products: More products

Download Mobile App





Sysmex Showcases Latest Laboratory Innovations and Technologies

By LabMedica International staff writers
Posted on 04 Feb 2025

Sysmex (Kobe, Japan) is participating at Medlab Middle East 2025 as a platinum sponsor where the company is showcasing its latest laboratory innovations and technologies and also hosting workshops. More...

At the 2025 edition of Medlab Middle East, Sysmex is highlighting BloodScience Workcell, its novel laboratory automation concept which smartly combines hematology and hemostasis testing in one interdisciplinary solution – to support physicians in obtaining a more holistic picture of their patients and to improve the workflow in the laboratory. BloodScience Workcell consolidates the workflow automation of EDTA and citrate blood sample tubes by combining hematology automation lines, XR-9000 or XN-9100, with the new CN track for hemostasis. Also featured is the UN-Series of urinalysis solutions which can automate a lab’s urinalysis work area according to required workflow preferences. With modular components to mix and match, labs can tailor a complete solution that is scalable to their current and future needs, providing a perfect fit and a secure investment.

Sysmex is also showcasing its comprehensive line of IVD flow cytometry products, headlined by the advanced PS-10 sample preparation system and the XF-1600 flow cytometer, in addition to an extensive portfolio of monoclonal antibodies and consumables. Sysmex is demonstrating CyFlow WA, its innovative Work Area Manager (WAM) software, which is the key to a smartly connected modern clinical flow cytometry lab. It integrates seamlessly with existing Sysmex lab equipment, acting as a powerful middleware solution bridging hematology and clinical flow cytometry data analysis.

Among its other solutions, Sysmex is showcasing HISCL-800, the latest addition to its HISCL family of automated immunoassay systems. The unique features of HISCL-800 include fast reaction time with throughput of up to 100 tests per hour, delivering highly sensitive and specific clinical results with small footprint, making it an ideal partner for small and medium-sized laboratories. With a fast reaction time for every parameter, it takes 17 mins to get the first test result. The HISCL-800’s rapid analysis enables laboratories to meet their reporting objectives, especially for STAT samples. Visitors to the Sysmex booth can also view digital displays of its cancer diagnostic solutions for breast cancer and colorectal cancer.


Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated MALDI-TOF MS System
EXS 3000
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The Simoa p-Tau 217 research assay measures phosphorylated tau in blood (Photo courtesy of Quanterix)

Ultra-Sensitive Blood Biomarkers Enable Population-Scale Insights into Alzheimer’s Pathology

Accurately estimating how many people carry Alzheimer’s disease pathology has long been a challenge, as traditional methods rely on small, clinic-based samples rather than the general population.... Read more

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.